Quarterly report pursuant to Section 13 or 15(d)

SUBSEQUENT EVENTS (Details Narrative)

v3.7.0.1
SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member] - Lewis & Clark Pharmaceuticals, Inc. [Member]
Jul. 31, 2017
shares
Subsidiary or Equity Method Investee [Line Items]  
Percentage of shares acquired 100.00%
Stock issued during period, shares 7,122,172